Literature DB >> 9003583

Involvement of trihydroxyconjugated bile salts in cholesterol assimilation by bifidobacteria.

K Tahri1, J P Grill, F Schneider.   

Abstract

To determine the conditions of cholesterol assimilation,various strains of Bifidobacterium species were cultured in the presence of cholesterol and bile salts. During culturing, Bifidobacterium breve ATCC 15700 assimilates cholesterol in the presence of oxgall at pH values lower than 6. This strain was selected to study the influence of conjugated (taurocholic acid) and deconjugated (cholic acid) bile salts on cholesterol assimilation. B. breve ATCC 15700 assimilated cholesterol(up to 51%) when cultures were undertaken in the presence of taurocholic acid, whereas less than 13% of the initial amount ofcholesterol was measured in the cells in the presence of cholic acid. Cultured in the presence of six individual di- or trihydroxyconjugated bile salts, bifidobacteria strains assimilated cholesterol. This assimilation appeared to be more important in the presence of trihydroxyconjugated bile salts (tauro- and glycocholic acids). It is concluded thattrihydroxyconjugated bile salts are involved in the assimilation of cholesterol by bifidobacteria.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9003583     DOI: 10.1007/s002849900148

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  6 in total

1.  Cholesterol assimilation by lactic acid bacteria and bifidobacteria isolated from the human gut.

Authors:  Dora I A Pereira; Glenn R Gibson
Journal:  Appl Environ Microbiol       Date:  2002-09       Impact factor: 4.792

2.  An in vitro study of the probiotic potential of a bile-salt-hydrolyzing Lactobacillus fermentum strain, and determination of its cholesterol-lowering properties.

Authors:  Dora I A Pereira; Anne L McCartney; Glenn R Gibson
Journal:  Appl Environ Microbiol       Date:  2003-08       Impact factor: 4.792

Review 3.  Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases.

Authors:  Manoj Kumar; Ravinder Nagpal; Rajesh Kumar; R Hemalatha; Vinod Verma; Ashok Kumar; Chaitali Chakraborty; Birbal Singh; Francesco Marotta; Shalini Jain; Hariom Yadav
Journal:  Exp Diabetes Res       Date:  2012-05-03

4.  Cholesterol-lowering potentials of lactic acid bacteria based on bile-salt hydrolase activity and effect of potent strains on cholesterol metabolism in vitro and in vivo.

Authors:  Cheng-Chih Tsai; Pei-Pei Lin; You-Miin Hsieh; Zi-yi Zhang; Hui-Ching Wu; Chun-Chih Huang
Journal:  ScientificWorldJournal       Date:  2014-11-03

Review 5.  Gut microbiota and cardiovascular disease: opportunities and challenges.

Authors:  Negin Kazemian; Morteza Mahmoudi; Frank Halperin; Joseph C Wu; Sepideh Pakpour
Journal:  Microbiome       Date:  2020-03-14       Impact factor: 14.650

6.  Anti-proliferative effects of Bifidobacterium adolescentis SPM0212 extract on human colon cancer cell lines.

Authors:  Do Kyung Lee; Seok Jang; Mi Jin Kim; Jung Hyun Kim; Myung Jun Chung; Kyung Jae Kim; Nam Joo Ha
Journal:  BMC Cancer       Date:  2008-10-27       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.